1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of Life lost, years lived with disability, and disability-adjusted lifeyears for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017; 3:524–48.
2. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23:700–13.
Article
3. Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017; 15:1833–43.
Article
4. Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015; 64:1881–8.
Article
5. Wu X, Chen VW, Ruiz B, Andrews P, Su LJ, Correa P. Incidence of esophageal and gastric carcinomas among American Asians/Pacific Islanders, whites, and blacks: subsite and histology differences. Cancer. 2006; 106:683–92.
6. Wu X, Chen VW, Andrews PA, Ruiz B, Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control. 2007; 18:585–93.
Article
7. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004; 99:582–8.
Article
8. Surveillance Research Program, National Cancer Institute. SEER*Stat software, version 8.3.4 [Internet]. Bethesda, MD: National Cancer Institute;2018. [cited 2018 Jun 2]. Available from:
http://seer.cancer.gov/seerstat.
9. Xie SH, Rabbani S, Petrick JL, Cook MB, Lagergren J. Racial and ethnic disparities in the incidence of esophageal cancer in the United States, 1992-2013. Am J Epidemiol. 2017; 186:1341–51.
Article
10. Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman ME. An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by area-socioeconomic position and race-ethnicity, 1992-2004. Am J Epidemiol. 2008; 167:889–99.
Article
11. Breen N, Scott S, Percy-Laurry A, Lewis D, Glasgow R. Health disparities calculator: a methodologically rigorous tool for analyzing inequalities in population health. Am J Public Health. 2014; 104:1589–91.
Article
12. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19:335–51.
Article
13. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol. 2004; 159:252–8.
14. Huerta-Franco MR, Banderas JW, Allsworth JE. Ethnic/racial differences in gastrointestinal symptoms and diagnosis associated with the risk of Helicobacter pylori infection in the US. Clin Exp Gastroenterol. 2018; 11:39–49.
15. Taylor VM, Ko LK, Hwang JH, Sin MK, Inadomi JM. Gastric cancer in Asian American populations: a neglected health disparity. Asian Pac J Cancer Prev. 2014; 15:10565–71.
Article
16. Jamal A, Homa DM, O'Connor E, Babb SD, Caraballo RS, Singh T, et al. Current cigarette smoking among adults: United States, 2005-2014. MMWR Morb Mortal Wkly Rep. 2015; 64:1233–40.
17. Clarke TC, Ward BW, Schiller JS. Early release of selected estimates based on data from the January-March 2016 National Health Interview Survey. Atlanta, GA: Centers for Disease Control and Prevention;2016.
18. Nagy P, Johansson S, Molloy-Bland M. Systematic review of time trends in the prevalence of
Helicobacter pylori infection in China and the USA. Gut Pathog. 2016; 8:8.
Article
19. Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013; 63:232–48.
Article
20. Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014; 371:2499–509.
Article
21. Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018; 154:390–405.
Article
22. Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013; 11:1399–412.
Article
23. Okosun IS, Choi ST, Boltri JM, Parish DC, Chandra KM, Dever GE, et al. Trends of abdominal adiposity in white, black, and Mexican-American adults, 1988 to 2000. Obes Res. 2003; 11:1010–7.
Article
24. El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, Genta RM, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004; 126:1692–9.
Article
25. Wen M, Kowaleski-Jones L, Fan JX. Ethnic-immigrant disparities in total and abdominal obesity in the US. Am J Health Behav. 2013; 37:807–18.
Article
26. Petrick JL, Nguyen T, Cook MB. Temporal trends of esophageal disorders by age in the Cerner Health Facts database. Ann Epidemiol. 2016; 26:151–4.
Article
27. Harper S, Lynch J. Selected comparisons of measures of health disparities: a review using databases relevant to healthy people 2010 cancer-related objectives. NCI Cancer Surveillance Monograph Series, No. 7. NIH Pub. No. 07-6281. Bethesda, MD: National Cancer Institute;2007.
29. Kindig D. Population health equity: rate and burden, race and class. JAMA. 2017; 317:467–8.